Product Code: 136960-05-23
Therapeutic Beds Market is Expected to Grow at 5.0% by 2031. Therapeutic beds is a consistently growing market due to the overall growth in chronic disease prevalence and geriatric patient population. Therapeutic beds are basically used in hospitals, clinics and in home-care. Ease of use in novel equipment has led to the introduction of therapeutic beds and mattresses into the retail sector. Major drivers of the therapeutic beds market are advent of innovative treatments that demand changes in hospital infrastructure, rise in the high-risk geriatric population, and the prevalence of chronic diseases.
Growing preference for home-care and assisted living has also increased demand for therapeutic beds. The introduction of innovative features such as lightweight, automation, adjustable height, and side railing, and others have further added to the demand for therapeutic beds through upgrading the existing products. Some of the restraining factors of this market are high pricing of new products. This market is highly competitive, with several local players manufacturing base-line products. Hospitals is still the major market segment for therapeutic beds. However, growing awareness among patient population particularly the geriatric and disabled group will serve as potential opportunities in this market.
Key players identified for the therapeutic beds market include but are not limited to:
- Hill Rom, Inc. (Baxter)
- Stryker Corp.
- Invacare Corp.
- Medline Industries
- Medical Depot, Inc.
- GF Health Products, Inc.
|
- Centromed Ltd.
- Arjo
- Amico Group of Companies
- Bakare Beds Ltd.
- Gendron, Inc.
- Hard Manufacturing Company, Inc.
|
Historical & Forecast Period
This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Therapeutic Beds market are as follows:
- Research and development budgets of manufacturers and government spending
- Revenues of key companies in the market segment
- Number of end users and consumption volume, price and value.
Geographical revenues generate by countries considered in the report:
Micro and macro environment factors that are currently influencing the Therapeutic Beds market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
Market Segmentation
Product
- Clinical Beds
- Regular Beds
- ICU Beds
- Pediatric Beds
- Birthing Beds
- Bariatric Beds
- Low Air Loss Beds
- Others
- Household Beds
- Accessories
Application
- Acute Care Beds
- Critical Care Beds
- Long-term Beds
End-use
- Hospital & Clinics
- Reproductive Care Centers
- Others
Region Segment (2021-2031; US$ Million)
- North America
- U.S.
- Canada
- Rest of North America
- UK and European Union
- UK
- Germany
- Spain
- Italy
- France
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- GCC
- Africa
- Rest of Middle East and Africa
Key questions answered in this report:
- What are the key micro and macro environmental factors that are impacting the growth of Therapeutic Beds market?
- What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
- Estimated forecast and market projections up to 2031.
- Which segment accounts for the fastest CAGR during the forecast period?
- Which market segment holds a larger market share and why?
- Are low and middle-income economies investing in the Therapeutic Beds market?
- Which is the largest regional market for Therapeutic Beds market?
- What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
- Which are the key trends driving Therapeutic Beds market growth?
- Who are the key competitors and what are their key strategies to enhance their market presence in the Therapeutic Beds market worldwide?
Table of Contents
1. Preface
- 1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted
2. Executive Summary
- 2.1. Market Snapshot: Global Therapeutic Beds Market
- 2.2. Global Therapeutic Beds Market, By Product, 2022 (US$ Million)
- 2.3. Global Therapeutic Beds Market, By Application, 2022 (US$ Million)
- 2.4. Global Therapeutic Beds Market, By End-use, 2022 (US$ Million)
- 2.5. Global Therapeutic Beds Market, By Geography, 2022 (US$ Million)
- 2.6. Attractive Investment Proposition by Geography, 2022
3. Therapeutic Beds Market: Competitive Analysis
- 3.1. Market Positioning of Key Therapeutic Beds Market Vendors
- 3.2. Strategies Adopted by Therapeutic Beds Market Vendors
- 3.3. Key Industry Strategies
- 3.4. Tier Analysis 2022 Versus 2031
4. Therapeutic Beds Market: Macro Analysis & Market Dynamics
- 4.1. Introduction
- 4.2. Global Therapeutic Beds Market Value, 2021 - 2031, (US$ Million)
- 4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
- 4.4. Impact Analysis of Drivers and Restraints
- 4.5. See-Saw Analysis
5. Therapeutic Beds Market: By Product, 2021-2031, USD (Million)
- 5.1. Market Overview
- 5.2. Growth & Revenue Analysis: 2022 Versus 2031
- 5.3. Market Segmentation
- 5.3.1. Clinical Beds
- 5.3.1.1. Regular Beds
- 5.3.1.2. ICU Beds
- 5.3.1.3. Pediatric Beds
- 5.3.1.4. Birthing Beds
- 5.3.1.5. Bariatric Beds
- 5.3.1.6. Low Air Loss Beds
- 5.3.1.7. Others
- 5.3.2. Household Beds
- 5.3.3. Accessories
6. Therapeutic Beds Market: By Application, 2021-2031, USD (Million)
- 6.1. Market Overview
- 6.2. Growth & Revenue Analysis: 2022 Versus 2031
- 6.3. Market Segmentation
- 6.3.1. Acute Care Beds
- 6.3.2. Critical Care Beds
- 6.3.3. Long-term Beds
7. Therapeutic Beds Market: By End-use, 2021-2031, USD (Million)
- 7.1. Market Overview
- 7.2. Growth & Revenue Analysis: 2022 Versus 2031
- 7.3. Market Segmentation
- 7.3.1. Hospital & Clinics
- 7.3.2. Reproductive Care Centers
- 7.3.3. Others
8. North America Therapeutic Beds Market, 2021-2031, USD (Million)
- 8.1. Market Overview
- 8.2. Therapeutic Beds Market: By Product, 2021-2031, USD (Million)
- 8.3. Therapeutic Beds Market: By Application, 2021-2031, USD (Million)
- 8.4. Therapeutic Beds Market: By End-use, 2021-2031, USD (Million)
- 8.5.Therapeutic Beds Market: By Region, 2021-2031, USD (Million)
- 8.5.1.North America
- 8.5.1.1. U.S.
- 8.5.1.1.1. Therapeutic Beds Market: By Product, 2021-2031, USD (Million)
- 8.5.1.1.1. Therapeutic Beds Market: By Application, 2021-2031, USD (Million)
- 8.5.1.1.1. Therapeutic Beds Market: By End-use, 2021-2031, USD (Million)
- 8.5.1.2. Canada
- 8.5.1.2.1. Therapeutic Beds Market: By Product, 2021-2031, USD (Million)
- 8.5.1.2.1. Therapeutic Beds Market: By Application, 2021-2031, USD (Million)
- 8.5.1.2.1. Therapeutic Beds Market: By End-use, 2021-2031, USD (Million)
- 8.5.1.3. Rest of North America
- 8.5.1.3.1. Therapeutic Beds Market: By Product, 2021-2031, USD (Million)
- 8.5.1.3.1. Therapeutic Beds Market: By Application, 2021-2031, USD (Million)
- 8.5.1.3.1. Therapeutic Beds Market: By End-use, 2021-2031, USD (Million)
9. UK and European Union Therapeutic Beds Market, 2021-2031, USD (Million)
- 9.1. Market Overview
- 9.2. Therapeutic Beds Market: By Product, 2021-2031, USD (Million)
- 9.3. Therapeutic Beds Market: By Application, 2021-2031, USD (Million)
- 9.4. Therapeutic Beds Market: By End-use, 2021-2031, USD (Million)
- 9.5.Therapeutic Beds Market: By Region, 2021-2031, USD (Million)
- 9.5.1.UK and European Union
- 9.5.1.1. UK
- 9.5.1.1.1. Therapeutic Beds Market: By Product, 2021-2031, USD (Million)
- 9.5.1.1.1. Therapeutic Beds Market: By Application, 2021-2031, USD (Million)
- 9.5.1.1.1. Therapeutic Beds Market: By End-use, 2021-2031, USD (Million)
- 9.5.1.2. Germany
- 9.5.1.2.1. Therapeutic Beds Market: By Product, 2021-2031, USD (Million)
- 9.5.1.2.1. Therapeutic Beds Market: By Application, 2021-2031, USD (Million)
- 9.5.1.2.1. Therapeutic Beds Market: By End-use, 2021-2031, USD (Million)
- 9.5.1.3. Spain
- 9.5.1.3.1. Therapeutic Beds Market: By Product, 2021-2031, USD (Million)
- 9.5.1.3.1. Therapeutic Beds Market: By Application, 2021-2031, USD (Million)
- 9.5.1.3.1. Therapeutic Beds Market: By End-use, 2021-2031, USD (Million)
- 9.5.1.4. Italy
- 9.5.1.4.1. Therapeutic Beds Market: By Product, 2021-2031, USD (Million)
- 9.5.1.4.1. Therapeutic Beds Market: By Application, 2021-2031, USD (Million)
- 9.5.1.4.1. Therapeutic Beds Market: By End-use, 2021-2031, USD (Million)
- 9.5.1.5. France
- 9.5.1.5.1. Therapeutic Beds Market: By Product, 2021-2031, USD (Million)
- 9.5.1.5.1. Therapeutic Beds Market: By Application, 2021-2031, USD (Million)
- 9.5.1.5.1. Therapeutic Beds Market: By End-use, 2021-2031, USD (Million)
- 9.5.1.6. Rest of Europe
- 9.5.1.6.1. Therapeutic Beds Market: By Product, 2021-2031, USD (Million)
- 9.5.1.6.1. Therapeutic Beds Market: By Application, 2021-2031, USD (Million)
- 9.5.1.6.1. Therapeutic Beds Market: By End-use, 2021-2031, USD (Million)
10. Asia Pacific Therapeutic Beds Market, 2021-2031, USD (Million)
- 10.1. Market Overview
- 10.2. Therapeutic Beds Market: By Product, 2021-2031, USD (Million)
- 10.3. Therapeutic Beds Market: By Application, 2021-2031, USD (Million)
- 10.4. Therapeutic Beds Market: By End-use, 2021-2031, USD (Million)
- 10.5.Therapeutic Beds Market: By Region, 2021-2031, USD (Million)
- 10.5.1.Asia Pacific
- 10.5.1.1. China
- 10.5.1.1.1. Therapeutic Beds Market: By Product, 2021-2031, USD (Million)
- 10.5.1.1.1. Therapeutic Beds Market: By Application, 2021-2031, USD (Million)
- 10.5.1.1.1. Therapeutic Beds Market: By End-use, 2021-2031, USD (Million)
- 10.5.1.2. Japan
- 10.5.1.2.1. Therapeutic Beds Market: By Product, 2021-2031, USD (Million)
- 10.5.1.2.1. Therapeutic Beds Market: By Application, 2021-2031, USD (Million)
- 10.5.1.2.1. Therapeutic Beds Market: By End-use, 2021-2031, USD (Million)
- 10.5.1.3. India
- 10.5.1.3.1. Therapeutic Beds Market: By Product, 2021-2031, USD (Million)
- 10.5.1.3.1. Therapeutic Beds Market: By Application, 2021-2031, USD (Million)
- 10.5.1.3.1. Therapeutic Beds Market: By End-use, 2021-2031, USD (Million)
- 10.5.1.4. Australia
- 10.5.1.4.1. Therapeutic Beds Market: By Product, 2021-2031, USD (Million)
- 10.5.1.4.1. Therapeutic Beds Market: By Application, 2021-2031, USD (Million)
- 10.5.1.4.1. Therapeutic Beds Market: By End-use, 2021-2031, USD (Million)
- 10.5.1.5. South Korea
- 10.5.1.5.1. Therapeutic Beds Market: By Product, 2021-2031, USD (Million)
- 10.5.1.5.1. Therapeutic Beds Market: By Application, 2021-2031, USD (Million)
- 10.5.1.5.1. Therapeutic Beds Market: By End-use, 2021-2031, USD (Million)
- 10.5.1.6. Rest of Asia Pacific
- 10.5.1.6.1. Therapeutic Beds Market: By Product, 2021-2031, USD (Million)
- 10.5.1.6.1. Therapeutic Beds Market: By Application, 2021-2031, USD (Million)
- 10.5.1.6.1. Therapeutic Beds Market: By End-use, 2021-2031, USD (Million)
11. Latin America Therapeutic Beds Market, 2021-2031, USD (Million)
- 11.1. Market Overview
- 11.2. Therapeutic Beds Market: By Product, 2021-2031, USD (Million)
- 11.3. Therapeutic Beds Market: By Application, 2021-2031, USD (Million)
- 11.4. Therapeutic Beds Market: By End-use, 2021-2031, USD (Million)
- 11.5.Therapeutic Beds Market: By Region, 2021-2031, USD (Million)
- 11.5.1.Latin America
- 11.5.1.1. Brazil
- 11.5.1.1.1. Therapeutic Beds Market: By Product, 2021-2031, USD (Million)
- 11.5.1.1.1. Therapeutic Beds Market: By Application, 2021-2031, USD (Million)
- 11.5.1.1.1. Therapeutic Beds Market: By End-use, 2021-2031, USD (Million)
- 11.5.1.2. Mexico
- 11.5.1.2.1. Therapeutic Beds Market: By Product, 2021-2031, USD (Million)
- 11.5.1.2.1. Therapeutic Beds Market: By Application, 2021-2031, USD (Million)
- 11.5.1.2.1. Therapeutic Beds Market: By End-use, 2021-2031, USD (Million)
- 11.5.1.3. Rest of Latin America
- 11.5.1.3.1. Therapeutic Beds Market: By Product, 2021-2031, USD (Million)
- 11.5.1.3.1. Therapeutic Beds Market: By Application, 2021-2031, USD (Million)
- 11.5.1.3.1. Therapeutic Beds Market: By End-use, 2021-2031, USD (Million)
12. Middle East and Africa Therapeutic Beds Market, 2021-2031, USD (Million)
- 12.1. Market Overview
- 12.2. Therapeutic Beds Market: By Product, 2021-2031, USD (Million)
- 12.3. Therapeutic Beds Market: By Application, 2021-2031, USD (Million)
- 12.4. Therapeutic Beds Market: By End-use, 2021-2031, USD (Million)
- 12.5.Therapeutic Beds Market: By Region, 2021-2031, USD (Million)
- 12.5.1.Middle East and Africa
- 12.5.1.1. GCC
- 12.5.1.1.1. Therapeutic Beds Market: By Product, 2021-2031, USD (Million)
- 12.5.1.1.1. Therapeutic Beds Market: By Application, 2021-2031, USD (Million)
- 12.5.1.1.1. Therapeutic Beds Market: By End-use, 2021-2031, USD (Million)
- 12.5.1.2. Africa
- 12.5.1.2.1. Therapeutic Beds Market: By Product, 2021-2031, USD (Million)
- 12.5.1.2.1. Therapeutic Beds Market: By Application, 2021-2031, USD (Million)
- 12.5.1.2.1. Therapeutic Beds Market: By End-use, 2021-2031, USD (Million)
- 12.5.1.3. Rest of Middle East and Africa
- 12.5.1.3.1. Therapeutic Beds Market: By Product, 2021-2031, USD (Million)
- 12.5.1.3.1. Therapeutic Beds Market: By Application, 2021-2031, USD (Million)
- 12.5.1.3.1. Therapeutic Beds Market: By End-use, 2021-2031, USD (Million)
13. Company Profile
- 13.1. Hill Rom, Inc. (Baxter)
- 13.1.1. Company Overview
- 13.1.2. Financial Performance
- 13.1.3. Product Portfolio
- 13.1.4. Strategic Initiatives
- 13.2. Stryker Corp.
- 13.2.1. Company Overview
- 13.2.2. Financial Performance
- 13.2.3. Product Portfolio
- 13.2.4. Strategic Initiatives
- 13.3. Invacare Corp.
- 13.3.1. Company Overview
- 13.3.2. Financial Performance
- 13.3.3. Product Portfolio
- 13.3.4. Strategic Initiatives
- 13.4. Medline Industries
- 13.4.1. Company Overview
- 13.4.2. Financial Performance
- 13.4.3. Product Portfolio
- 13.4.4. Strategic Initiatives
- 13.5. Medical Depot, Inc.
- 13.5.1. Company Overview
- 13.5.2. Financial Performance
- 13.5.3. Product Portfolio
- 13.5.4. Strategic Initiatives
- 13.6. GF Health Products, Inc.
- 13.6.1. Company Overview
- 13.6.2. Financial Performance
- 13.6.3. Product Portfolio
- 13.6.4. Strategic Initiatives
- 13.7. Centromed Ltd.
- 13.7.1. Company Overview
- 13.7.2. Financial Performance
- 13.7.3. Product Portfolio
- 13.7.4. Strategic Initiatives
- 13.8. Arjo
- 13.8.1. Company Overview
- 13.8.2. Financial Performance
- 13.8.3. Product Portfolio
- 13.8.4. Strategic Initiatives
- 13.9. Amico Group of Companies
- 13.9.1. Company Overview
- 13.9.2. Financial Performance
- 13.9.3. Product Portfolio
- 13.9.4. Strategic Initiatives
- 13.10. Bakare Beds Ltd.
- 13.10.1. Company Overview
- 13.10.2. Financial Performance
- 13.10.3. Product Portfolio
- 13.10.4. Strategic Initiatives
- 13.11. Gendron, Inc.
- 13.11.1. Company Overview
- 13.11.2. Financial Performance
- 13.11.3. Product Portfolio
- 13.11.4. Strategic Initiatives
- 13.12. Hard Manufacturing Company, Inc.
- 13.12.1. Company Overview
- 13.12.2. Financial Performance
- 13.12.3. Product Portfolio
- 13.12.4. Strategic Initiatives